Tag: New England Journal of Medicine
Browse our exclusive articles!
Long-Term Insulin – Are These Studies Changing the Lives of Diabetics?
There are already at least 540 million type 2 diabetics worldwide. Many of them eventually need daily insulin as basic therapy over the...
Cheap and deadly – rotting alive: new zombie drug is raging in the US
Undead wandering aimlessly. Closer to the end than life. Skin and flesh rot. Not a scene from the TV series "The...
This morning-after pill also protects against diseases
Researchers have discovered a new drug. A single-dose antibiotic as a “morning after pill” is intended to significantly reduce infection with bacterial sexually...
Vaccination against RSV infections in the starting blocks
Vaccines against infection or serious illness caused by respiratory syncytial virus (RSV) for the elderly could be available soon. Successful studies recently appeared...
US agency approves Alzheimer’s drug
The U.S. Food and Drug Administration (FDA) has granted accelerated approval for an antibody drug designed to slow the progression of early-stage Alzheimer's disease....
